Replies to post #8797 on Soligenix Inc (SNGX)

[Maps0117]

Possible takeover reasons...

Three Phase 3 assets, two with data readout next year
Cutaneous T-cell lymphoma (SGX301)
Pivotal study in progress with results expected 1H 2019
Oral mucositis in head & neck cancer (SGX942)
Pivotal study in progress with results expected 2H 2019
Pediatric Crohn’s disease (SGX203)
Pivotal study targeted to begin 2H 2018, contingent upon additional funding
and/or partnership

Go SNGX